Evidence map›Paper›PMID 42756127›Full record

ArticleFrontiers in neuroscience2026

A proof-of-concept application of gene set enrichment analysis principles to olfactory phenotyping in Parkinson's disease.

Jakub Šofranko, Natalia Hunarova, Michaela Škorvanová, Martin Kolisek

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jakub ŠofrankoBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
Natalia HunarovaDepartment of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
Michaela ŠkorvanováBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.
Martin KolisekBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: While gene set enrichment analysis (GSEA) framework is widely used on transcriptomics or proteomics data, its applications beyond "omics" data has not been extensively explored. Its principal nature enables it to apply to any dataset where variables can be rationally sorted into categories, or sets. This study demonstrates a novel application of GSEA outside of its traditional use by applying the framework to clinical olfactory phenotyping data. Methods: We applied the GSEA framework to University of Pennsylvania Smell Identification Test (UPSIT) results from Parkinson's disease patients and healthy controls. Odors were classified into seven distinct functional categories, and a rank-based running sum was used to identify coordinated changes across those categories. Results: This approach revealed an exploratory pattern of negative enrichment within the "citrus/fresh" odor category in Parkinson's disease patients. The computational pipeline was systematically evaluated alongside synthetic positive, negative, and permutation-based sanity checks. Discussion: Category-specific patterns of olfactory loss may offer additional insight into neurodegenerative processes, suggesting potential value for more refined olfactory phenotyping in Parkinson's disease. This proof-of-concept highlights how established genomic algorithms can be directly adapted to clinical tools, questionnaires, or cognitive data where variables can be meaningfully grouped. However, the results here should be considered exploratory.

Indexed as

GSEAneurodegenerationolfactoryParkinson’s diseaseUPSIT

Identifiers

PMID42756127
PMCPMC13582382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.